COŞKUN, B. N. Et Al. 2014. Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.3 , 101-105.

COŞKUN, B. N., Oksuz, M. F., ERMURAT, S., Tufan, A. N., ORUÇOĞLU, N., Dogan, A., ... DALKILIÇ, H. E.(2014). Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.3, 101-105.

COŞKUN, BELKIS Et Al. "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis," EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.3, 101-105, 2014

COŞKUN, BELKIS N. Et Al. "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.3, pp.101-105, 2014

COŞKUN, B. N. Et Al. (2014) . "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.3, pp.101-105.

@article{article, author={BELKIS NİHAN COŞKUN Et Al. }, title={Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis}, journal={EUROPEAN JOURNAL OF RHEUMATOLOGY}, year=2014, pages={101-105} }